Open Access

Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Gastrodia elata Blume in the treatment of ischemic stroke

  • Authors:
    • Yuan Luo
    • Pu Chen
    • Liping Yang
    • Xiaohua Duan
  • View Affiliations

  • Published online on: November 3, 2022     https://doi.org/10.3892/etm.2022.11678
  • Article Number: 742
  • Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gastrodia elata Blume (GEB) is widely used to treat cardio-cerebrovascular disease in China and in traditional Chinese medicine it is considered to be a dispelling wind and dredging collateral. However, the mechanism and active components of the plant in treating ischemic stroke (IS) remain unclear. The present study aimed to identify the active components and mechanism of GEB in treating IS using network pharmacology and molecular docking technology. Network analysis predicted 752 potential targets from 14 compounds in GEB, sharing 32 key targets with IS-associated targets. Gene Ontology analysis of key targets showed that ‘oxidative stress’, ‘immune response’ and ‘regulation of blood circulation’ were significantly enriched. Kyoto Encyclopedia of Genes and Genomes pathway analysis indicated that the key targets regulated 11 representative pathways including ‘arachidonic acid metabolism’, ‘lipid and galactose metabolism’. In the protein-protein interaction network, five core targets, including toll-like receptor agonist, STAT3, myeloperoxidase (MPO), prostaglandin-endoperoxide synthase and matrix metalloproteinase (MMP)9, were identified and successfully docked with four active components: Palmitic acid, alexandrin, para-hydroxybenzaldehyde and gastrodin. Alexandrin, para-hydroxybenzaldehyde, and gastrodin are closely related to brain ischemia/reperfusion damage and repair. Therefore, to further verify the mechanism of action of three active components in the second part, we established the HT22 oxygen-glucose deprivation-reperfusion (OGD/R) model. Cell Counting Kit-8 assay and western blot analysis demonstrated that these three active components of GEB regulated core targets of molecular docking, such as STAT3, MPO and MMP9. In vitro experiments showed that OGD/R decreased cell survival, while this effect was reversed by the three active components of GEB. In addition, western blot analysis indicated that alexandrin upregulated expression of phosphorylated-STAT3, para-hydroxybenzaldehyde downregulated MPO and gastrodin downregulated MMP9. Therefore, the present study showed that GEB may prevent and treat IS via interaction between the active components and the main targets, which is key for investigating the efficacy of traditional Chinese medicine.

Related Articles

Journal Cover

December-2022
Volume 24 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Luo Y, Chen P, Yang L and Duan X: Network pharmacology and molecular docking analysis on molecular targets and mechanisms of <em>Gastrodia elata </em>Blume in the treatment of ischemic stroke. Exp Ther Med 24: 742, 2022
APA
Luo, Y., Chen, P., Yang, L., & Duan, X. (2022). Network pharmacology and molecular docking analysis on molecular targets and mechanisms of <em>Gastrodia elata </em>Blume in the treatment of ischemic stroke. Experimental and Therapeutic Medicine, 24, 742. https://doi.org/10.3892/etm.2022.11678
MLA
Luo, Y., Chen, P., Yang, L., Duan, X."Network pharmacology and molecular docking analysis on molecular targets and mechanisms of <em>Gastrodia elata </em>Blume in the treatment of ischemic stroke". Experimental and Therapeutic Medicine 24.6 (2022): 742.
Chicago
Luo, Y., Chen, P., Yang, L., Duan, X."Network pharmacology and molecular docking analysis on molecular targets and mechanisms of <em>Gastrodia elata </em>Blume in the treatment of ischemic stroke". Experimental and Therapeutic Medicine 24, no. 6 (2022): 742. https://doi.org/10.3892/etm.2022.11678